The Blood and Marrow Transplant (BMT) Program at West Cancer Center has received accreditation for both autologous and allogenic transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT).
FACT accreditation is based upon compliance with the most comprehensive standards in the field. The BMT Program, a collaboration between West Cancer Center, Methodist Healthcare and the University of Tennessee Health Science Center, has achieved this accreditation in just over a year since its establishment.
The BMT Program is housed on the campus of Methodist University Hospital and provides stem cell transplantation and cellular therapy for a variety of hematologic malignancies, including Leukemia, Myelodysplastic Syndromes, Lymphoma and Multiple Myeloma, as well as bone marrow failure syndromes and aplastic anemia.